Biodesix Inc.

1.59-0.1100-6.47%Vol 102.88K1Y Perf -86.55%
May 18th, 2022 16:00 DELAYED
BID1.55 ASK1.90
Open1.68 Previous Close1.70
Pre-Market- After-Market-
 - -  - -%
Target Price
7.50 
Analyst Rating
Moderate Buy 1.67
Potential %
371.70 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     36.57
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     44.03
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.86 
Earnings Rating
Market Cap63.27M 
Earnings Date
11th May 2022
Alpha-0.11 Standard Deviation0.20
Beta1.50 

Today's Price Range

1.511.73

52W Range

1.3116.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
12.58%
1 Month
26.39%
3 Months
-46.37%
6 Months
-73.68%
1 Year
-86.55%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BDSX1.59-0.1100-6.47
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.38-0.50-31.58
Q04 2021-0.50-0.492.00
Q03 2021-0.50-0.500.00
Q02 2021-0.31-0.41-32.26
Q01 2021-0.13-0.23-76.92
Q04 2020-0.48-0.2547.92
Q03 2020--31.93-
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.38
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume102.88K
Shares Outstanding39.79K
Shares Float24.66M
Trades Count767
Dollar Volume164.35K
Avg. Volume395.93K
Avg. Weekly Volume220.19K
Avg. Monthly Volume401.89K
Avg. Quarterly Volume565.71K

Biodesix Inc. (NYSE: BDSX) stock closed at 1.7 per share at the end of the most recent trading day (a 1.19% change compared to the prior day closing price) with a volume of 92.25K shares and market capitalization of 63.27M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 186 people. Biodesix Inc. CEO is Scott Hutton.

The one-year performance of Biodesix Inc. stock is -86.55%, while year-to-date (YTD) performance is -67.86%. BDSX stock has a five-year performance of %. Its 52-week range is between 1.31 and 16.395, which gives BDSX stock a 52-week price range ratio of 1.86%

Biodesix Inc. currently has a PE ratio of -1.20, a price-to-book (PB) ratio of 3.67, a price-to-sale (PS) ratio of 2.61, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -43.78%, a ROC of -78.34% and a ROE of -141.75%. The company’s profit margin is -79.18%, its EBITDA margin is -65.10%, and its revenue ttm is $25.64 Million , which makes it $0.64 revenue per share.

Of the last four earnings reports from Biodesix Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.38 for the next earnings report. Biodesix Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Biodesix Inc. is Moderate Buy (1.67), with a target price of $7.5, which is +371.70% compared to the current price. The earnings rating for Biodesix Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biodesix Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biodesix Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.10, ATR14 : 0.27, CCI20 : 2.91, Chaikin Money Flow : 0.24, MACD : -0.03, Money Flow Index : 67.33, ROC : 5.59, RSI : 47.74, STOCH (14,3) : 42.17, STOCH RSI : 0.66, UO : 47.24, Williams %R : -57.83), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biodesix Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
2.00
Moderate Buy
2.00

Biodesix Inc.

Biodesix Inc is a data-driven diagnostic solutions company. The company's artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The revenue is derived from two sources namely, providing diagnostic tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development and testing services.

CEO: Scott Hutton

Telephone: +1 303 417-0500

Address: 2970 Wilderness Place, Boulder 80301, CO, US

Number of employees: 186

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

67%33%

Bearish Bullish

75%25%

News

Stocktwits